AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Purple Biotech Ltd.

Proxy Solicitation & Information Statement Oct 25, 2020

7004_rns_2020-10-24_08b419b5-923e-4d1d-b8fc-d60f84c1436a.pdf

Proxy Solicitation & Information Statement

Open in Viewer

Opens in native device viewer

VOTING SLIP FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS

Company name: Kitov Pharma Ltd., company no. 520031238

Company address (for submission and delivery of Voting Slips): One Azrieli Center, Round Tower, 19th Floor, Tel Aviv 6701101, Israel, email: [email protected]; or fax: +972-153-39311321, Attn.: Gil Efron, Deputy Chief Executive Officer and Chief Financial Officer

Meeting date: Thursday, December 3, 2020, at 4:30 p.m. (Israel time).

Meeting type: Annual General Meeting (the "Meeting").

Record Date: Tuesday, October 27, 2020

Shareholder details:

Shareholder name:

Israeli identification number:

For shareholders who do not have an Israeli identification card:

Passport number:

Country of issue:

Valid until:

For shareholders that are corporations:

Corporation number:

Country of incorporation:

Is the shareholder a "Principal Shareholder1 ", "Senior Officer of the Company2 " or an "Institutional Investor3 "? Yes/No (circle as appropriate)

  • 1 As defined in Section 1 of the Israel Securities Law, 5728-1968 (the "Securities Law").
  • 2 As defined in Section 37(d) of the Securities Law.
  • 3 As defined in Regulation 1 of the Supervision of Financial Services Regulations (Provident Funds)(Participation of a Management Company at a General Meeting), 5769-2009 as well as a Manager of Mutual Funds as per the meaning in the Mutual Funds Law, 5754-1999.

MANNER OF VOTING

(Check or mark "X" clearly in each column in accordance with your voting decision.)

Matter Manner of Voting
For Against Abstain
Proposal 1
To approve the election of two directors to serve as
second class directors, each for a three year term
until the annual general meeting to be held in 2023,
and until their respective successors are duly elected
and qualified.
Proposal 1.A.
Steven Steinberg
Proposal 1.B.
Simcha Rock
Proposal 2
To approve an amendment to the Company's
Memorandum
of
Association
and
Articles
of
Association to provide for the change in the
Company's name to "Purple Biotech Ltd." or to such
other name that contains the word "Purple" as the
management of the Company shall determine and as
shall be approved by the Israel Registrar of
Companies.
Proposal 3
To approve the reappointment of Somekh Chaikin,
Certified Public Accountants (Israel), a member of
KPMG International, as the Company's independent
registered public accountants for a period of three
years
until
the
annual
general
meeting
of
shareholders to be held in 2023.

Date Signature

For shareholders holding shares through a stock exchange member (in accordance with Section 177(1) of the Companies Law, this Voting Slip is only valid when accompanied by a certification of ownership. For shareholders registered in the Company's shareholder registry, this Voting Slip will only be valid when accompanied by a photocopy of a government-issued photograph identification (e.g., passport, identification card or certificate of incorporation (as the case may be)).

Talk to a Data Expert

Have a question? We'll get back to you promptly.